[Current status of immunotherapy of malignant tumors].
D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D001943:Breast Neoplasms / Q000628:therapy; D001984:Bronchial Neoplasms / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D005770:Gastrointestinal Neoplasms / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy; D009163:Mycobacterium bovis; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012516:Osteosarcoma / Q000628:therapy; D011425:Propionibacterium acnes
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine
Zum heutigen Stand der Immuntherapie maligner Tumoren.